Market Opportunities

Each year, 1.7 million Americans get hospital-acquitted infections; 99,000 die as a result. Costs associated with HAI are staggering: upwards of $35 billion annually. The healthcare industry is highly motivated to identify meaningful solutions, particularly because of the growing challenge of killing and controlling pathogenic microbes. BIOSAFE Defenses’ research and current efforts are focused on … Continued


Opportunity

BIOSAFE Defenses is poised to revolutionize how disinfectants are viewed and used. More than ten years in the making, the labs that developed the technology received millions of dollars in funding from the U.S. Defense Threat Reduction Agency to address growing concerns over biowarfare agents. The result is a new class of synthetic antimicrobials suitable … Continued